Top Industry Leaders in the Cervical Cancer Treatment Market
Latest Cervical Cancer Treatment Companies Update
Merck & Co. Keytruda (pembrolizumab) approved for recurrent/metastatic cervical cancer with PD-L1 positive status, providing a new treatment option for this aggressive form of the disease.Ongoing clinical trials investigating Keytruda in combination with other therapies for cervical cancer.
Roche Holding AG Avastin (bevacizumab) approved for first-line treatment of advanced cervical cancer in combination with chemotherapy, demonstrating improved survival outcomes.Developing Tecentriq (atezolizumab) for cervical cancer treatment, with promising results in Phase II clinical trials.
GlaxoSmithKline Cervarix and Gardasil 9, HPV vaccines from GSK, are widely used for prevention of cervical cancer.Focus on increasing vaccination rates and expanding access to HPV vaccines in developing countries
AstraZeneca Lynparza (olaparib) approved for the treatment of advanced cervical cancer with BRCA mutations, offering a targeted therapy option for specific patients.Ongoing research on other PARP inhibitors for cervical cancer treatment.
List of Cervical Cancer Treatment Key Companies in the Market
-
Pfizer Inc.
-
GlaxoSmithKline
-
Bristol-Myers Squibb Company
-
ALLERGAN
-
Actavis Pharma Company
-
Eli Lilly and Company
-
Alnylam Pharmaceuticals, Inc
-
Hetero
-
Biocon
-
Novartis
-
Genentech USA